Skip to content

RX Antwerpen Zuid

Active Private limited companyfounded 2024active for 2 yearsPrins Boudewijnlaan 111, 2610 AntwerpKBO/BCE: BE 1005.268.705 subsidiary of
Part of the group 18 companies

Lifetime

1 annual account with figures
peak of €302,487 in 2025
€302,487 
lowest -€31,286 in 2025
-€31,286 
peak of -€28,286 in 2025
-€28,286 
€781,453 
Board4 names since 2024
3 directors and 2 others
Owners2 names in the annual accounts
100%
Documentsfilings and deeds
10-03-2026143 days before the deadline
2025micro format
Loss of €31,286First year with figures

Key points

from the 2025 annual accounts

Equity

-€28,286
2025

Debts exceed assets in financial year 2025.

Debts

€781,453 104% of the balance sheet
Financial debts 66%Suppliers 0%Taxes and wages 2%Other 32%

Of this, €125,838 falls due within a year.

Position in the sector

-3.8%

Lower solvency than 95% of companies in human health. Sector median 63.0% · 21,347 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 1,556 companies had the same profile as RX Antwerpen Zuid has now. Each dot stands for 4 companies, two years later.

91.4%
were still trading
3.8%
stopped another way
4.6%
went bankrupt
  • Micro
  • 2 to 5 years old
  • negative equity
  • a small loss

Another 0.3% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,556 companies, not a prediction for RX Antwerpen Zuid. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Managing director
Director, since 26-01-2024
Director, since 26-01-2024
Director
  • 100%equity €23.6m (2025) · annual accounts 2025 of
Board & ownership

Recent changes

appointed as director General meeting of 06-07-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:1005268705
New establishment in Antwerp Radiologie Mertens Bollen, Fruithoflaan 54
Incorporation , (managing director) and appointed · Registered office clause: Prins Boudewijnlaan 111, 2610 Antwerpen (district Wilrijk) · Founder: · published on 30-01-2024 · Gazette deed
All 6 events

Comparable companies

same main activity, similar in size and age
Company
RX Antwerpen Zuid Antwerp €753,167 €302,487 -3.8% -
OOGCENTRUM EOS Mol €662,396 €291,676 10.7% -
GS Consult Heusden-Zolder €725,283 €327,767 73.2% -
DOKTER STEFF DE SMET, PATHOLOGIE Oostkamp €679,594 €303,554 87.2% -
MEDICALIA Thuin €689,223 €286,652 42.7% -
Dr Anciaux Marc Oudenaarde €769,924 €299,707 64.5% -
JULIEN JOSKIN Chaudfontaine €823,762 €331,889 73.5% -

These companies have the same main activity as RX Antwerpen Zuid: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €662,000 and €824,000, founded between 2023 and 2024.

Official details

Source: KBO
Status
Active since 26-01-2024Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Establishment units
2.356.284.8042610 Antwerp, since 26-01-2024
2.388.527.6042600 Antwerp, since 01-02-2026
Financial year end
31 December
Peppol
Reachable since 27-03-2026
Company details

Annual accounts 2025

≈ €460,000estimated
€753,167
Employeeson 31-12-2025
1
Filing
Filed on 10-03-2026, 143 days before the end of the filing period
Financials

Insights on RX Antwerpen Zuid

RX Antwerpen Zuid has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity of -€28,286 and a net result of -€31,286.

Its solvency ranks better than 5% of 21,347 sector peers (NACE 86) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about RX Antwerpen Zuid

What is the company number of RX Antwerpen Zuid?
The company number of RX Antwerpen Zuid is 1005.268.705. The VAT number is the same number with BE in front: BE 1005.268.705.
Where is RX Antwerpen Zuid based?
The registered office is at Prins Boudewijnlaan 111, 2610 Antwerp.Company details
What does RX Antwerpen Zuid do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of RX Antwerpen Zuid?
RX Antwerpen Zuid is a private limited company (BV).
When was RX Antwerpen Zuid founded?
RX Antwerpen Zuid was founded on 26-01-2024.
Is RX Antwerpen Zuid still active?
Yes, RX Antwerpen Zuid is an active enterprise in the KBO register.
How many employees does RX Antwerpen Zuid have?
RX Antwerpen Zuid had an average of 2.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of RX Antwerpen Zuid?
The turnover in financial year 2025 is ≈ €460,000. This figure is estimated from the gross margin of €302,487 and 31 comparable companies (NACE 86220). It probably lies between €400,000 and €630,000.
Is RX Antwerpen Zuid profitable?
In financial year 2025, RX Antwerpen Zuid made a loss of €31,286.
Where can I find the annual accounts of RX Antwerpen Zuid?
RX Antwerpen Zuid filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.